noel palmer

U.S.: Marijuana-Derived CBD Products Introduced For Dogs, Cats, Horses

MarysPetsLouieCat

Denver, Colorado-based Mary's Pets on Thursday announced the availability of pet-care products made from American cannabidiol (CBD).

"More and more humans are benefitting from cannabinoid medicine. Shouldn't our furry companions also have access to natural relief?" said Nicole Smith, CEO, Mary's Pets, manufacturer of pet-care CBD supplements made from Colorado-grown hemp.

Smith is also CEO and owner of Mary's Nutritionals, a CBD supplement company using the same hemp-based cannabinoids for people, and Mary's Medicinals, a cannabis company best known for its transdermal patch.

"We've combined our award-winning research and development capabilities and experiences designing medical cannabis products for humans with the latest veterinary science to offer the first transdermal CBD product for our feline, canine and equine friends," Smith said.

The premier offering in the Mary's Pets line is Mary's CBD Gel, a clinically formulated, precisely dosed, transdermal lotion designed to relieve symptoms in mammals of all types.

"Everyone gets sick and feels pain, our pets included," said Noel Palmer, Ph.D., chief scientist, Mary's Pets. "For most animals, CBD can be effectively used as an anti-inflammatory agent, pain-relieving compound and anti-epileptic — just as with humans."

Mary's Pets Gel is enriched with hemp-derived CBD organically grown by Elite Botanicals in northern Colorado. CBD is a non-psychoactive compound that is reported to have anti-convulsive, anti-anxiety, anti-psychotic, anti-nausea, anti-rheumatoid arthritic and sedative properties.

Colorado: Mary's Medicinals Welcomes Dr. Noel Palmer As Chief Scientist

DrNoelPalmer-MarysMedicinals(MedicalMarijuana411.com)

As part of what it calls its "ongoing mission to provide clean, effective and accurately dosed plant-based health and wellness products," Mary's Medicinals today announced that it has enlisted Noel Palmer, Ph.D. as chief scientist. In this role, Dr. Palmer will direct and manage all research, development and testing for current and future products.

"We're thrilled to add Noel's expertise to our team," said Nicole Smith, CEO, Mary's Medicinals. "As one of the most respected researchers in the cannabis industry, his understanding of plant chemistry will allow us to continue to improve the efficacy and accuracy of our products, and his skill set will lend itself perfectly to the development of our new Mary's Nutritionals line."

Dr. Palmer brings 15 years of experience as a laboratory scientist with an emphasis on plant properties to Mary's Medicinals. A member of the International Cannabinoid Research Society, his R&D and testing of product potency and efficacy is award winning.

Most recently, he was recognized as Americans for Safe Access Researcher of the Year 2014. In collaboration with ASA and the American Herbal Products Association, he was closely involved in drafting the Industry Standards for Laboratory Testing of cannabis.

"Mary's Medicinals has established itself as a leader in the creation of effective, quality cannabis medicine," Palmer said. "I look forward to applying my understanding of the powerful properties of plants to finding new ways to help patients find relief."

Syndicate content